Worldwide Mycoplasma Testing Industry to 2024 - Key Drivers, Challenges and Trends
Dublin, Sept. 28, 2020 (GLOBE NEWSWIRE) -- The "Global Mycoplasma Testing Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.
The mycoplasma testing market is poised to grow by $ 445.57 million during 2020-2024 progressing at a CAGR of 11% during the forecast period. The reports on mycoplasma testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing focus on R&D of biopharmaceuticals, increasing initiatives and funding for mycoplasma testing and rise in adoption of real-time mycoplasma testing.
The mycoplasma testing market analysis includes end-user segment and geographic landscapes. This study identifies the growing M&A and partnerships between CROs, and pharmaceutical and biotechnology companies as one of the prime reasons driving the mycoplasma testing market growth during the next few years. Also, increasing healthcare expenditure and technological advances will lead to sizable demand in the market.
The mycoplasma testing market covers the following areas:
Mycoplasma testing market sizing
Mycoplasma testing market forecast
Mycoplasma testing market industry analysis
This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading mycoplasma testing market vendors that include Agilent Technologies Inc., ATCC, Becton, Dickinson and Co., Charles River Laboratories International Inc., F. Hoffmann-La Roche Ltd., InvivoGen, Lonza Group Ltd., Merck KGaA, Norgen Biotek Corp., and Thermo Fisher Scientific Inc.. Also, the mycoplasma testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
This study presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influences. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.
The market research report provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Key Topics Covered:
1. Executive Summary
Market Overview
2. Market Landscape
Market ecosystem
Value chain analysis
3. Market Sizing
Market definition
Market segment analysis
Market size 2019
Market outlook: Forecast for 2019 - 2024
4. Five Forces Analysis
Five Force Summary
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition
5. Market Segmentation by Product
Market segments
Comparison by Product
Consumables - Market size and forecast 2019-2024
Systems - Market size and forecast 2019-2024
Market opportunity by Product
6. Market Segmentation by End-user
Pharmaceutical and biotechnology companies
CROs
Academic research institutes
Cell banks
Others
7. Customer Landscape
8. Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2019-2024
Europe - Market size and forecast 2019-2024
Asia - Market size and forecast 2019-2024
ROW - Market size and forecast 2019-2024
Key leading countries
Market opportunity by geography
Volume driver - demand led growth
Market challenges
Market trends
9. Vendor Landscape
Vendor landscape
Landscape disruption
Competitive scenario
10. Vendor Analysis
Vendors covered
Market positioning of vendors
Agilent Technologies Inc.
ATCC
Charles River Laboratories International Inc.
F. Hoffmann-La Roche Ltd.
InvivoGen
Lonza Group Ltd.
Merck KGaA
Norgen Biotek Corp.
Thermo Fisher Scientific Inc.
11. Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations
For more information about this report visit https://www.researchandmarkets.com/r/ftzjj9
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900